Format

Send to

Choose Destination
J Cancer Res Ther. 2019;15(2):267-268. doi: 10.4103/jcrt.JCRT_910_18.

Programmed cell death protein-1 inhibitor for the treatment of hepatocellular carcinoma: "A sharp sword".

Author information

1
Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.
2
Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
PMID:
30964095
DOI:
10.4103/jcrt.JCRT_910_18
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center